PAS
KNTE

Point72 Asia (Singapore)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Point72 Asia (Singapore)’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,095
Closed -$37.5K – 1612
2024
Q1 		$37.5K Buy
14,095
+11,895
+541% +$31.6K 0.01% 858
2023
Q4 		$5.21K Buy
+2,200
New +$5.21K ﹤0.01% 531